Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q1 2024 ▲▼ | Q2 2024 ▲▼ | Change ▲▼ | Q1 2024 ▲▼ | Q2 2024 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Labcorp Holdings Inc.(LH) | 0 | 245,902 | +245,902 | $0 | $50.04M | 18.87% | +$50.04M |
| Teleflex Incorporated(TFX) | 33,878 | 111,078 | +77,200 | $7.66M | $23.36M | 8.81% | +$15.70M |
| Zimmer Biomet Holdings, Inc.(ZBH) | 74,179 | 155,304 | +81,125 | $9.79M | $16.86M | 6.36% | +$7.06M |
| Smith & Nephew plcADR(SNN) | 0 | 579,619 | +579,619 | $0 | $14.36M | 5.42% | +$14.36M |
| Organon & Co.(OGN) | 479,023 | 608,096 | +129,073 | $9.01M | $12.59M | 4.75% | +$3.58M |
| GSK plcADR(GSK) | 263,445 | 312,000 | +48,555 | $11.29M | $12.01M | 4.53% | +$718.1K |
| Corbus Pharmaceuticals Holdings, Inc.(CRBP) | 0 | 225,165 | +225,165 | $0 | $10.19M | 3.84% | +$10.19M |
| Vaxart, Inc.(VXRT) | 0 | 14,764,991 | +14,764,991 | $0 | $9.85M | 3.72% | +$9.85M |
| Tyra Biosciences, Inc.(TYRA) | 535,741 | 600,294 | +64,553 | $8.79M | $9.60M | 3.62% | +$812.5K |
| Abbott Laboratories | 0 | 89,500 | +89,500 | $0 | $9.30M | 3.51% | +$9.30M |
| The Cigna Group(CI) | 76,086 | 26,786 | -49,300 | $27.63M | $8.85M | 3.34% | -$18.78M |
| Kenvue Inc.(KVUE) | 0 | 485,000 | +485,000 | $0 | $8.82M | 3.32% | +$8.82M |
| Disc Medicine, Inc.(IRON) | 0 | 192,000 | +192,000 | $0 | $8.65M | 3.26% | +$8.65M |
| Erasca, Inc.(ERAS) | 2,427,184 | 2,874,536 | +447,352 | $5.00M | $6.78M | 2.56% | +$1.78M |
| Biodesix, Inc.(BDSX) | 0 | 4,347,855 | +4,347,855 | $0 | $6.65M | 2.51% | +$6.65M |
| Astria Therapeutics Inc | 410,267 | 510,267 | +100,000 | $5.77M | $4.64M | 1.75% | -$1.13M |
| ANI Pharmaceuticals, Inc.(ANIP) | 87,354 | 71,740 | -15,614 | $6.04M | $4.57M | 1.72% | -$1.47M |
| Bausch Plus Lomb Corp | 0 | 302,710 | +302,710 | $0 | $4.40M | 1.66% | +$4.40M |
| PMV Pharmaceuticals, Inc.(PMVP) | 0 | 2,708,408 | +2,708,408 | $0 | $4.39M | 1.65% | +$4.39M |
| Zymeworks Inc.(ZYME) | 0 | 491,128 | +491,128 | $0 | $4.18M | 1.58% | +$4.18M |
| BridgeBio Pharma, Inc.(BBIO) | 203,174 | 125,174 | -78,000 | $6.28M | $3.17M | 1.20% | -$3.11M |
| Apogee Therapeutics Inc | 78,000 | 78,000 | 0 | $5.18M | $3.07M | 1.16% | -$2.11M |
| Context Therapeutics Inc.(CNTX) | 0 | 1,328,352 | +1,328,352 | $0 | $2.66M | 1.00% | +$2.66M |
| Modular Med Inc | 1,539,352 | 1,539,352 | 0 | $2.85M | $2.43M | 0.92% | -$415.6K |
| Stoke Therapeutics, Inc.(STOK) | 225,496 | 175,301 | -50,195 | $3.04M | $2.37M | 0.89% | -$675.9K |
| Enanta Pharmaceuticals, Inc.(ENTA) | 177,004 | 177,004 | 0 | $3.09M | $2.30M | 0.87% | -$794.7K |
| Third Harmonic Bio Inc | 163,363 | 163,363 | 0 | $1.54M | $2.12M | 0.80% | +$581.6K |
| Nuvation Bio Inc.CL A(NUVB) | 1,336,231 | 668,115 | -668,116 | $4.86M | $1.95M | 0.74% | -$2.91M |
| ARS Pharmaceuticals, Inc.(SPRY) | 536,163 | 217,864 | -318,299 | $5.48M | $1.85M | 0.70% | -$3.63M |
| Ventyx Biosciences Inc | 378,000 | 778,924 | +400,924 | $2.08M | $1.80M | 0.68% | -$279.7K |
| COMPASS Pathways plcADS(CMPS) | 0 | 293,417 | +293,417 | $0 | $1.77M | 0.67% | +$1.77M |
| Arcutis Biotherapeutics, Inc.(ARQT) | 635,969 | 159,626 | -476,343 | $6.30M | $1.48M | 0.56% | -$4.82M |
| X4 Pharmaceuticals, Inc.(XFOR) | 3,588,427 | 2,499,800 | -1,088,627 | $4.99M | $1.45M | 0.55% | -$3.54M |
| Prelude Therapeutics Incorporated(PRLD) | 320,394 | 320,394 | 0 | $1.52M | $1.22M | 0.46% | -$298.0K |
| Aprea Therapeutics, Inc.(APRE) | 276,603 | 276,603 | 0 | $1.85M | $1.13M | 0.42% | -$724.7K |
| Rapt Therapeutics Inc | 315,000 | 315,000 | 0 | $2.83M | $960.8K | 0.36% | -$1.87M |
| Avalo Therapeutics, Inc.(AVTX) | 10,151 | 71,458 | +61,307 | $220.8K | $891.1K | 0.34% | +$670.3K |
| Foghorn Therapeutics Inc.(FHTX) | 121,672 | 121,672 | 0 | $816.4K | $699.6K | 0.26% | -$116.8K |
| Boundless Bio, Inc.(BOLD) | 143,000 | 162,058 | +19,058 | $2.04M | $627.2K | 0.24% | -$1.41M |
| Verastem, Inc.(VSTM) | 0 | 133,412 | +133,412 | $0 | $397.6K | 0.15% | +$397.6K |
| Nyxoah S ASHS SHS | 50,839 | 50,839 | 0 | $685.8K | $354.3K | 0.13% | -$331.5K |
| Nextcure Inc | 130,000 | 130,000 | 0 | $289.9K | $206.7K | 0.08% | -$83.2K |
| Aslan Pharmaceuticals LtdADS | 254,150 | 254,150 | 0 | $156.4K | $76.2K | 0.03% | -$80.1K |
| Humacyte, Inc.W EXP 08 27 202(HUMA) | 49,998 | 49,998 | 0 | $31.0K | $70.5K | 0.03% | +$39.5K |
| Rocket Pharmaceuticals, Inc.W EXP 09 02 202(RCKT) | 400,000 | 400,000 | 0 | $109.9K | $28.9K | 0.01% | -$81.0K |
| Caremax IncW EXP 06 08 202 | 12,808 | 12,808 | 0 | $302 | $200 | 0.00% | -$102 |
| CytomX Therapeutics, Inc.(CTMX) | 1,598,590 | 0 | -1,598,590 | $3.48M | $0 | — | -$3.48M |
| Embecta Corp.(EMBC) | 585,418 | 0 | -585,418 | $7.77M | $0 | — | -$7.77M |
| Fusion Pharmaceuticals Inc | 243,035 | 0 | -243,035 | $5.18M | $0 | — | -$5.18M |
| Globus Medical, Inc.CL A(GMED) | 393,420 | 0 | -393,420 | $21.10M | $0 | — | -$21.10M |
| Healthcare Services Group, Inc.(HCSG) | 421,317 | 0 | -421,317 | $5.26M | $0 | — | -$5.26M |
| Humacyte, Inc.(HUMA) | 2,000,000 | 0 | -2,000,000 | $6.22M | $0 | — | -$6.22M |
| Integra LifeSciences Holdings Corporation(IART) | 137,000 | 0 | -137,000 | $4.86M | $0 | — | -$4.86M |
| IDEAYA Biosciences, Inc.(IDYA) | 33,007 | 0 | -33,007 | $1.45M | $0 | — | -$1.45M |
| Ironwood Pharmaceuticals, Inc.CL A(IRWD) | 149,400 | 0 | -149,400 | $1.30M | $0 | — | -$1.30M |
| Laboratory Corporation Of America Holdings | 225,902 | 0 | -225,902 | $49.35M | $0 | — | -$49.35M |
| Madrigal Pharmaceuticals, Inc.(MDGL) | 51,000 | 0 | -51,000 | $13.62M | $0 | — | -$13.62M |
| Medtronic plcSHS(MDT) | 105,000 | 0 | -105,000 | $9.15M | $0 | — | -$9.15M |
| Ocular Therapeutix, Inc.(OCUL) | 383,026 | 0 | -383,026 | $3.49M | $0 | — | -$3.49M |
| Revance Therapeutics Inc | 468,871 | 0 | -468,871 | $2.31M | $0 | — | -$2.31M |
| Scholar Rock Holding Corporation(SRRK) | 273,720 | 0 | -273,720 | $4.86M | $0 | — | -$4.86M |
| Vincerx Pharma Inc | 102,049 | 0 | -102,049 | $516.4K | $0 | — | -$516.4K |